Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein aggregation and its consequences for human disease.

Christopher M Dobson1

  • 1Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK. cmd44@cam.ac.uk

Protein and Peptide Letters
|March 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their Oligomers.

Frontiers in neuroscience·2021
Same author

Parallel and Sequential Pathways of Molecular Recognition of a Tandem-Repeat Protein and Its Intrinsically Disordered Binding Partner.

Biomolecules·2021
Same author

ThX - a next-generation probe for the early detection of amyloid aggregates.

Chemical science·2021
Same author

Machine learning-aided protein identification from multidimensional signatures.

Lab on a chip·2021
Same author

Distinct responses of human peripheral blood cells to different misfolded protein oligomers.

Immunology·2021
Same author

Comparative Studies in the A30P and A53T α-Synuclein <i>C. elegans</i> Strains to Investigate the Molecular Origins of Parkinson's Disease.

Frontiers in cell and developmental biology·2021

Protein aggregation in vivo causes human disorders like Alzheimer's disease and type II diabetes. This overview examines amyloid fibril formation, their pathogenic properties, and potential suppression strategies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pathology

Background:

  • Proteins naturally exist in soluble, functional states.
  • Under certain conditions, proteins can aggregate into insoluble forms.
  • In vivo protein aggregation is linked to prevalent human diseases such as Alzheimer's and type II diabetes.

Purpose of the Study:

  • To provide an overview of current knowledge on fibrillar protein aggregates.
  • To explain the formation mechanisms of these aggregates.
  • To discuss the origins and potential suppression of their pathogenic properties.

Main Methods:

  • Literature review and synthesis of existing research on protein aggregation.
  • Analysis of the structural characteristics of amyloid fibrils.

Related Experiment Videos

  • Discussion of biological pathways involved in protein aggregation and disease.

    • Main Results:

    • Protein aggregation, particularly into amyloid fibrils, is a common pathological feature in various human diseases.
    • Understanding the formation of these aggregates is crucial for disease intervention.
    • Pathogenic properties are associated with both the aggregates and their precursors.

    Conclusions:

    • Further research into protein aggregation mechanisms is essential.
    • Developing strategies to suppress the pathogenic properties of protein aggregates is a key therapeutic goal.
    • Targeting protein aggregation pathways may offer new avenues for treating associated human disorders.